BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Endosc. Sep 16, 2025; 17(9): 109396
Published online Sep 16, 2025. doi: 10.4253/wjge.v17.i9.109396
Table 2 Clinical/endoscopic data of study cases, n (%)
OutcomeSubmucosal injection group
Starch-based polysaccharide solution group
Crystalloid-oil emulsion solution group
χ2 statistic
P value
Polypectomy technique
    Endoscopic mucosal resection75/99 (75.7)73/79 (92.4)8.69< 0.01
    Endoscopic submucosal dissection24/99 (24.2)6/79 (7.6)
Polyp location
    Right colon63/99 (63.6)42/79 (53.2)1.990.16
    Left colon36/99 (36.3)37/79 (46.8)
Polyp size
    < 2 cm28/99 (28.2)26/79 (32.9)3.210.20
    2-4 cm45/99 (45.5)41/79 (51.9)
    ≥ 4 cm26/99 (26.2)12/79 (15.2)
Quality of lift
    Adequate71/99 (71.7)57/79 (72.2)1.300.52
    Not adequate12/99 (12.1)13/79 (16.5)
    Not reported16/99 (16.6)9/79 (11.4)
Polypectomy resection
    En bloc32/99 (32.3)8/79 (10.1)12.43< 0.01
    Piecemeal67/99 (67.7)71/79 (89.9)
Intraprocedural bleeding requiring intervention
    Yes20/99 (20.2)35/79 (44.3)11.95< 0.01
    No79/99 (79.8)44/79 (55.7)
30-day adverse events
    Rectal bleeding2/99 (2.0)7/79 (8.9)6.65< 0.01
    Bowel perforation0/99 (0.0)2/79 (2.5)


Write to the Help Desk